Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity

v3.21.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Preferred Stock
Common stock
Additional paid-in capital
Accumulated deficit
Total
Balances at Dec. 31, 2018   $ 5,838 $ 1,244,273 $ (1,481,973) $ (231,862)
Balances (in Shares) at Dec. 31, 2018   5,838,149      
Surrender of common shares in settlement of due from stockholder balance   $ (575) (1,608,258)   (1,608,833)
Surrender of common shares in settlement of due from stockholder balance (in Shares)   (574,991)      
Series A Convertible Preferred share issuance (Alliance MMA) $ 629   5,980,501   5,981,130
Series A Convertible Preferred share issuance (Alliance MMA) (in Shares) 629,138        
Issuance of common stock in settlement of Series A Convertible Preferred Stock contractual fee   $ 73 209,885   209,958
Issuance of common stock in settlement of Series A Convertible Preferred Stock contractual fee (in Shares)   73,156      
Conversion of Series A Convertible Preferred Stock into common stock $ (240) $ 634 (394)    
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (240,571) 633,082      
Issuance of common stock   $ 1,283 5,883,078   5,884,361
Issuance of common stock (in Shares)   1,283,124      
Series A Convertible Preferred share issuance
Conversion of notes payable - related party into Series A Convertible Preferred share issuance $ 190   1,899,810   1,900,000
Conversion of notes payable - related party into Series A Convertible Preferred share issuance (in Shares) 190,000        
Exercise of warrants   $ 11 67,537   67,548
Exercise of warrants (in Shares)   11,075      
Settlement of disputed contractual claim   $ 20 117,982   118,002
Settlement of disputed contractual claim (in Shares)   19,801      
Issuance of warrants in settlement of lease dispute     66,275   66,275
Shares issued in cashless exercise of warrants   $ 4 (4)    
Shares issued in cashless exercise of warrants (in Shares)   3,732      
Stock-based compensation related to founder’s transfers of common shares to contractors     5,322,930   5,322,930
Stock-based compensation related to employee and contractor equity awards   $ 78 2,159,247   2,159,325
Stock-based compensation related to employee and contractor equity awards (in Shares)   78,290      
Common stock issued in settlement of litigation   $ 25 74,975   75,000
Common stock issued in settlement of litigation (in Shares)   24,843      
Stock and warrant dividend     (1,705,722)   (1,705,722)
Net Loss       (11,312,500) (11,312,500)
Balances at Dec. 31, 2019 $ 579 $ 7,391 19,712,115 (12,794,473) 6,925,612
Balances (in Shares) at Dec. 31, 2019 578,567 7,390,261      
Conversion of Series A Convertible Preferred Stock into common stock $ (494) $ 1,299 (805)    
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (493,695) 1,299,200      
Settlement of Accounts Payable   $ 441 2,747,086   2,747,527
Settlement of Accounts Payable (in Shares)   441,567      
Shares issued in cashless exercise of warrants   $ 416 (416)    
Shares issued in cashless exercise of warrants (in Shares)   415,904      
Shares issued in cashless exercise of options   $ 86 (86)    
Shares issued in cashless exercise of options (in Shares)   86,424      
Warrants exercised for cash   $ 7 38,563   38,570
Warrants exercised for cash (in Shares)   7,000      
Shares issued to current and former employees and directors   $ 218 146,007   146,225
Shares issued to current and former employees and directors (in Shares)   218,402      
Stock based compensation     3,138,432   3,138,432
Shares issued for equity financing   $ 38 139,962   140,000
Shares issued for equity financing (in Shares)   36,842      
Net Loss       (7,402,350) (7,402,350)
Balances at Dec. 31, 2020 $ 85 $ 9,896 $ 25,920,858 $ (20,196,823) $ 5,734,016
Balances (in Shares) at Dec. 31, 2020 84,872 9,895,600